AC Immune SA (ACIU) is a publicly traded Healthcare sector company. As of July 7, 2026, ACIU trades at $2.50 with a market cap of $255.45M and a P/E ratio of 0.00. ACIU moved +0.00% today. Year to date, ACIU is -20.32%; over the trailing twelve months it is +21.26%. Its 52-week range spans $1.43 to $4.00. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces ACIU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ACIU financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ACIU recently traded at $2.50. Market cap is $255.45M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $2.50 |
| Market Cap | $255.45M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.00 |
| 52-Week Low | $1.43 |
| Volume | 9.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover ACIU: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.